International union of basic and clinical pharmacology. XC. multisite pharmacology

Recommendations for the nomenclature of receptor allosterism and allosteric ligands

Arthur Christopoulos (Lead / Corresponding author), Jean-Pierre Changeux, William A. Catterall, Doriano Fabbro, Thomas P. Burris, John A. Cidlowski, Richard W. Olsen, John A. Peters, Richard R. Neubig, Jean-Philippe Pin, Patrick M. Sexton, Terry P. Kenakin, Frederick J. Ehlert, Michael Spedding, Christopher J. Langmead

    Research output: Contribution to journalArticle

    105 Citations (Scopus)

    Abstract

    Allosteric interactions play vital roles in metabolic processes and signal transduction and, more recently, have become the focus of numerous pharmacological studies because of the potential for discovering more target-selective chemical probes and therapeutic agents. In addition to classic early studies on enzymes, there are now examples of small molecule allosteric modulators for all superfamilies of receptors encoded by the genome, including ligand- and voltage-gated ion channels, G protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases. As a consequence, a vast array of pharmacologic behaviors has been ascribed to allosteric ligands that can vary in a target-, ligand-, and cell-/tissue-dependent manner. The current article presents an overview of allostery as applied to receptor families and approaches for detecting and validating allosteric interactions and gives recommendations for the nomenclature of allosteric ligands and their properties.
    Original languageEnglish
    Pages (from-to)918-947
    Number of pages30
    JournalPharmacological Reviews
    Volume66
    Issue number4
    DOIs
    Publication statusPublished - Oct 2014

    Fingerprint

    Clinical Pharmacology
    Terminology
    Pharmacology
    Ligands
    Ligand-Gated Ion Channels
    Receptor Protein-Tyrosine Kinases
    Cytoplasmic and Nuclear Receptors
    G-Protein-Coupled Receptors
    Signal Transduction
    Genome
    Enzymes
    Therapeutics

    Cite this

    Christopoulos, Arthur ; Changeux, Jean-Pierre ; Catterall, William A. ; Fabbro, Doriano ; Burris, Thomas P. ; Cidlowski, John A. ; Olsen, Richard W. ; Peters, John A. ; Neubig, Richard R. ; Pin, Jean-Philippe ; Sexton, Patrick M. ; Kenakin, Terry P. ; Ehlert, Frederick J. ; Spedding, Michael ; Langmead, Christopher J. / International union of basic and clinical pharmacology. XC. multisite pharmacology : Recommendations for the nomenclature of receptor allosterism and allosteric ligands. In: Pharmacological Reviews. 2014 ; Vol. 66, No. 4. pp. 918-947.
    @article{ea7825ba06ca43e7830219a7ebf5cdb4,
    title = "International union of basic and clinical pharmacology. XC. multisite pharmacology: Recommendations for the nomenclature of receptor allosterism and allosteric ligands",
    abstract = "Allosteric interactions play vital roles in metabolic processes and signal transduction and, more recently, have become the focus of numerous pharmacological studies because of the potential for discovering more target-selective chemical probes and therapeutic agents. In addition to classic early studies on enzymes, there are now examples of small molecule allosteric modulators for all superfamilies of receptors encoded by the genome, including ligand- and voltage-gated ion channels, G protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases. As a consequence, a vast array of pharmacologic behaviors has been ascribed to allosteric ligands that can vary in a target-, ligand-, and cell-/tissue-dependent manner. The current article presents an overview of allostery as applied to receptor families and approaches for detecting and validating allosteric interactions and gives recommendations for the nomenclature of allosteric ligands and their properties.",
    author = "Arthur Christopoulos and Jean-Pierre Changeux and Catterall, {William A.} and Doriano Fabbro and Burris, {Thomas P.} and Cidlowski, {John A.} and Olsen, {Richard W.} and Peters, {John A.} and Neubig, {Richard R.} and Jean-Philippe Pin and Sexton, {Patrick M.} and Kenakin, {Terry P.} and Ehlert, {Frederick J.} and Michael Spedding and Langmead, {Christopher J.}",
    note = "U.S. Government work not protected by U.S. copyright.",
    year = "2014",
    month = "10",
    doi = "10.1124/pr.114.008862",
    language = "English",
    volume = "66",
    pages = "918--947",
    journal = "Pharmacological Reviews",
    issn = "0031-6997",
    publisher = "American Society for Pharmacology and Experimental Therapeutics",
    number = "4",

    }

    Christopoulos, A, Changeux, J-P, Catterall, WA, Fabbro, D, Burris, TP, Cidlowski, JA, Olsen, RW, Peters, JA, Neubig, RR, Pin, J-P, Sexton, PM, Kenakin, TP, Ehlert, FJ, Spedding, M & Langmead, CJ 2014, 'International union of basic and clinical pharmacology. XC. multisite pharmacology: Recommendations for the nomenclature of receptor allosterism and allosteric ligands', Pharmacological Reviews, vol. 66, no. 4, pp. 918-947. https://doi.org/10.1124/pr.114.008862

    International union of basic and clinical pharmacology. XC. multisite pharmacology : Recommendations for the nomenclature of receptor allosterism and allosteric ligands. / Christopoulos, Arthur (Lead / Corresponding author); Changeux, Jean-Pierre; Catterall, William A.; Fabbro, Doriano; Burris, Thomas P.; Cidlowski, John A.; Olsen, Richard W.; Peters, John A.; Neubig, Richard R.; Pin, Jean-Philippe; Sexton, Patrick M.; Kenakin, Terry P.; Ehlert, Frederick J.; Spedding, Michael; Langmead, Christopher J.

    In: Pharmacological Reviews, Vol. 66, No. 4, 10.2014, p. 918-947.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - International union of basic and clinical pharmacology. XC. multisite pharmacology

    T2 - Recommendations for the nomenclature of receptor allosterism and allosteric ligands

    AU - Christopoulos, Arthur

    AU - Changeux, Jean-Pierre

    AU - Catterall, William A.

    AU - Fabbro, Doriano

    AU - Burris, Thomas P.

    AU - Cidlowski, John A.

    AU - Olsen, Richard W.

    AU - Peters, John A.

    AU - Neubig, Richard R.

    AU - Pin, Jean-Philippe

    AU - Sexton, Patrick M.

    AU - Kenakin, Terry P.

    AU - Ehlert, Frederick J.

    AU - Spedding, Michael

    AU - Langmead, Christopher J.

    N1 - U.S. Government work not protected by U.S. copyright.

    PY - 2014/10

    Y1 - 2014/10

    N2 - Allosteric interactions play vital roles in metabolic processes and signal transduction and, more recently, have become the focus of numerous pharmacological studies because of the potential for discovering more target-selective chemical probes and therapeutic agents. In addition to classic early studies on enzymes, there are now examples of small molecule allosteric modulators for all superfamilies of receptors encoded by the genome, including ligand- and voltage-gated ion channels, G protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases. As a consequence, a vast array of pharmacologic behaviors has been ascribed to allosteric ligands that can vary in a target-, ligand-, and cell-/tissue-dependent manner. The current article presents an overview of allostery as applied to receptor families and approaches for detecting and validating allosteric interactions and gives recommendations for the nomenclature of allosteric ligands and their properties.

    AB - Allosteric interactions play vital roles in metabolic processes and signal transduction and, more recently, have become the focus of numerous pharmacological studies because of the potential for discovering more target-selective chemical probes and therapeutic agents. In addition to classic early studies on enzymes, there are now examples of small molecule allosteric modulators for all superfamilies of receptors encoded by the genome, including ligand- and voltage-gated ion channels, G protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases. As a consequence, a vast array of pharmacologic behaviors has been ascribed to allosteric ligands that can vary in a target-, ligand-, and cell-/tissue-dependent manner. The current article presents an overview of allostery as applied to receptor families and approaches for detecting and validating allosteric interactions and gives recommendations for the nomenclature of allosteric ligands and their properties.

    U2 - 10.1124/pr.114.008862

    DO - 10.1124/pr.114.008862

    M3 - Article

    VL - 66

    SP - 918

    EP - 947

    JO - Pharmacological Reviews

    JF - Pharmacological Reviews

    SN - 0031-6997

    IS - 4

    ER -